Abstract

Chronic Bronchopulmonary Disease (CBPD) is a progressive lung disease that includes chronic obstructive pulmonary disease (COPD) and chronic bronchitis, which causes long-term respiratory symptoms, airflow limitation, and decreased quality of life. Despite advancements in treatment, there is still no definitive cure, and current therapies primarily focus on symptom management. This review explores recent developments in therapeutic strategies for CBPD, particularly focusing on novel pharmacologic agents, biologics, and non-pharmacologic interventions. Research in the fields of anti-inflammatory drugs, immune modulators, and gene therapy has shown promise in addressing the underlying pathophysiology of the disease. Additionally, innovations in pulmonary rehabilitation and personalized medicine approaches are contributing to improving patient outcomes. The integration of cutting-edge technologies, such as telemedicine and precision medicine, may further enhance treatment efficacy. This paper aims to provide an updated perspective on the evolving landscape of CBPD management and the potential impact of new therapies on patient care.